ZA956099B - Method of establishing tonic ovarian estrogen secretion for extended therapeutic regimens. - Google Patents

Method of establishing tonic ovarian estrogen secretion for extended therapeutic regimens.

Info

Publication number
ZA956099B
ZA956099B ZA9506099A ZA956099A ZA956099B ZA 956099 B ZA956099 B ZA 956099B ZA 9506099 A ZA9506099 A ZA 9506099A ZA 956099 A ZA956099 A ZA 956099A ZA 956099 B ZA956099 B ZA 956099B
Authority
ZA
South Africa
Prior art keywords
establishing
therapeutic regimens
estrogen secretion
extended therapeutic
ovarian estrogen
Prior art date
Application number
ZA9506099A
Other languages
English (en)
Inventor
Gary D Hodgen
Audrey Phillips
Original Assignee
Hampton Roads Medical College
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hampton Roads Medical College filed Critical Hampton Roads Medical College
Publication of ZA956099B publication Critical patent/ZA956099B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K17/00—Carrier-bound or immobilised peptides; Preparation thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Reproductive Health (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)
  • Toxicology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
ZA9506099A 1994-07-22 1995-07-21 Method of establishing tonic ovarian estrogen secretion for extended therapeutic regimens. ZA956099B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US27959394A 1994-07-22 1994-07-22

Publications (1)

Publication Number Publication Date
ZA956099B true ZA956099B (en) 1997-02-18

Family

ID=23069633

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9506099A ZA956099B (en) 1994-07-22 1995-07-21 Method of establishing tonic ovarian estrogen secretion for extended therapeutic regimens.

Country Status (8)

Country Link
US (1) US5658884A (lt)
KR (1) KR970704460A (lt)
JO (1) JO1879B1 (lt)
LT (1) LT4341B (lt)
MY (1) MY121568A (lt)
RO (1) RO118794B1 (lt)
UA (1) UA51627C2 (lt)
ZA (1) ZA956099B (lt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6265393B1 (en) 1998-08-07 2001-07-24 Heinrichs William Leroy Prevention of endometriosis signs or symptons
US6703367B1 (en) 1999-04-27 2004-03-09 Praecis Pharmaceuticals Inc. Methods for treating hot flashes and gynaecomastia
US7005418B1 (en) * 1999-09-23 2006-02-28 Zentaris Gmbh Method for the therapeutic management of extrauterine proliferation of endometrial tissue, chronic pelvic pain and fallopian tube obstruction
NZ534836A (en) * 1999-09-23 2007-07-27 Zentaris Gmbh Method for the therapeutic management of extrauterine proliferatoin of endometrial tissue, chronic pelvic pain and fallopian tube obstruction
AU2011308775B2 (en) * 2010-10-01 2016-11-17 Indiana University Research And Technology Corporation Treatment of symptoms associated with menopause
EP3560555A1 (en) * 2018-04-26 2019-10-30 LifeArc A composition for treating one or more estrogen related diseases

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5211952A (en) * 1991-04-12 1993-05-18 University Of Southern California Contraceptive methods and formulations for use therein

Also Published As

Publication number Publication date
LT97021A (lt) 1998-02-25
RO118794B1 (ro) 2003-11-28
JO1879B1 (en) 1996-07-25
US5658884A (en) 1997-08-19
MY121568A (en) 2006-02-28
LT4341B (lt) 1998-05-25
UA51627C2 (uk) 2002-12-16
KR970704460A (ko) 1997-09-06

Similar Documents

Publication Publication Date Title
AP9600840A0 (en) Treatment of ovarian estrogen dependent conditions
GB2314737B (en) Method of enabling handoff
GB2323397B (en) Method of, and apparatus for, completing a well
EP0719064A3 (en) Multimode radiotelephone
PL327827A1 (en) Method of retarding the skin photoageing process
PL317930A1 (en) Oxalydine compounds, method of obtaining them and therapeutic agents
ZA959260B (en) Seaming apparatus
AU4017395A (en) Method for treating anxiety
ZA988674B (en) 21-Hydroy-6,19-oxidoprogesterone (21OH-6OP) for treating excess of glucocorticoids
PL313041A1 (en) Method of ensuring safe communication for desired connection and apparatus therefor
IL114655A0 (en) Method of establishing tonic ovarian estrogen secretion for extended therapeutic regimens
GB9410320D0 (en) Novel therapeutic method
PL330843A1 (en) Method of obtaining 17-esters of 9alpha, 21-dihalo-pregnano-11beta, 17alpha-diol-20-ones
LT97021A (lt) Toninės kiaušidžių estrogeno sekrecijos sureguliavimas pailgintiems terapiniams režimams
GB9710628D0 (en) Method for topical treatment of androgenic alopecia
AU4017195A (en) Method for treating anxiety
EP0769904A4 (en) METHOD FOR TREATING ANXIETIES
GB9418826D0 (en) Method of piling
GB9509930D0 (en) Method for preparing certain acetonitriles
GB0107221D0 (en) Method of,and apparatus for,completing a well
NZ328739A (en) Treatment of estrogen therapy using 8,9-dehydroesterone
KR0122183Y1 (en) Apparatus for controlling ring of telephone
LTIP2042A (en) Method for making of silicate-colour
HUP9600100A3 (en) Process for modify of sugarmanufacturing technology
PL303142A1 (en) Method of obtaining photosensibilising preparations